Related News

• Arista Networks, Lam Research among market cap stock movers on Thursday | 2026-10-15
  Thursday’s market has witnessed notable swings in various stocks based on multiple factors. Today, stocks like Eli Lilly and TransUnion are rallying, while others like Arista Networks and Vicor Corp are facing declines.
• Eli Lilly Says New Drug Drives Comprehensive Disease Control in Ulcerative Colitis Patients | 2026-10-15
  New data show Eli Lilly's Omvoh helps ulcerative colitis and Crohn's disease patients achieve long-term, comprehensive disease control.
• Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years | 2026-10-15
  Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 7.7% on an annualized basis producing an average annual return of 16.65%. Currently, Eli Lilly has a market capitalization of $1.04 trillion.
• Lilly confirms date and conference call for third-quarter 2026 financial results announcement | 2026-10-15
  INDIANAPOLIS, Oct. 15, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2026 financial results on October 29, 2026. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial...
• Nasdaq Sheds 1.65% as Russell 2000 Sinks to RSI 28, Oil Climbs While Gold and Silver Slide | 2026-10-14
  Stock Preachers News Commentary VANCOUVER, BC, Oct. 14, 2026 /PRNewswire/ -- Stocks skidded midweek as the Nasdaq Composite dropped 449 points, or 1.65%, to 26,755.24, pulling its weekly loss to 2.23%. The S&P 500 fell 1.10% on the day and 1.18% for the week, while the Russell 2000...
• Eli Lilly, Arm among market cap stock movers on Wednesday | 2026-10-14
  Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Eli Lilly (LLY) are rallying, while stocks like Arm (ARM) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.
• Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda | 2026-10-14
  SAN DIEGO, Oct. 14, 2026 /PRNewswire/ -- Equity Insider News Commentary - Global spending on cancer medicines reached $252 billion in 2024 and is forecast to exceed $400 billion by 2028, according to the IQVIA Institute, with the United States accounting for roughly 46% of the total. The...
• Biogen is set for big gains on slate of trial data releases, JPMorgan says | 2026-10-12
  Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.
• Eli Lilly-backed TRex Bio closes day flat after IPO | 2026-10-09
  TRex Bio closes at $14 IPO price despite volatility in its trading debut.
• Record Highs Beckon for Big Caps as Small Caps Lag and Deal Flow Builds | 2026-10-09
  Stock Preachers News Commentary NEW YORK, Oct. 9, 2026 /PRNewswire/ -- Large caps closed out the week near record territory, with the S&P 500 and Nasdaq Composite both finishing higher even after a rocky start to the week. Small caps told a different story, with the Russell 2000 slipping...

News source: finlight